Decision(s): The Minister approved the changes to the Prescribed List (Jersey) as recommended by the Pharmaceutical Benefit Advisory Committee from the meeting held on 18 January 2011. To be included from 1 April 2011 as green items: Duloxetine (as hydrochloride) capsules 30mg; 60mg (Cymbalta brand only) Nortriptyline tablets 10mg, 25mg Pregabalin capsules (all strengths) classification change to green status Zanamivir dry powder for inhalation 5mg/dose Dioralyte oral powder sachets Liquifilm Tears eye drops (preservative free) containing polyvinyl alcohol 1.4%, povidone 0.6% per 0.4mL unit dose Sodium valproate modified-release (Episenta brand) capsules 150mg, 300mg; granules 500mg/sachet, 1g/sachet Tramadol modified-release capsules 100mg, 150mg, 200mg Oseltamivir capsules 30mg, 45mg, 75mg; suspension 60mg/5Ml To be included as amber items (for initiation/stabilisation in secondary care before transfer to primary care) Exenatide injection 250mcg/mL; 5mcg/dose pre-filled pen. 10mcg/dose pre-filled pen Liraglutide injection 6mg/mL 2x3mL pre-filled pen, 3x3mL pre-filled pen Saxagliptin tablets 5mg Sitagliptin tablets 100mg; Sitagliptin/metformin tablets 50mg/1000mg Vildagliptin tablets 50mg; vildagliptin/metformin tablets 50/850mg, 50/1000mg To be included as amber items (subject to shared care protocols) Dronedarone tablets 400mg Ropinirole modified-release tablets 2mg, 4mg, 8mg To give notice that the following items be deleted from 1 July 2011 Tramadol modified –release tablets (all strengths) |